Crossmark

Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor

Crossref DOI link: https://doi.org/10.1186/s12974-018-1087-7

Published Online: 2018-02-21

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dang, Duy-Khanh

Shin, Eun-Joo

Kim, Dae-Joong

Tran, Hai-Quyen

Jeong, Ji Hoon

Jang, Choon-Gon

Nah, Seung-Yeol

Jeong, Jung Hwan

Byun, Jae Kyung

Ko, Sung Kwon

Bing, Guoying

Hong, Jau-Shyong

Kim, Hyoung-Chun http://orcid.org/0000-0003-0420-795X
Funding

Funding for this research was provided by:

Forestry Technology Projects (S111415L020100)

Korea Food and Drug Administration, Republic of Korea (14182MFDS979)
More Information

Article History

Received: 31 July 2017

Accepted: 2 February 2018

First Online: 21 February 2018

Ethics approval

: All animals were treated in accordance with the National Institutes of Health (NIH) Guide for the Humane Care and Use of Laboratory Animals (NIH Publication No. 85–23, 1985;ExternalRef removed). The present study was performed in accordance with the Institute for Laboratory Research (ILAR) Guidelines for the Care and Use of Laboratory Animals.

: Not applicable.

: The authors declare that they have no competing interests

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below